中华神经外科杂志
中華神經外科雜誌
중화신경외과잡지
Chinese Journal of Neurosurgery
2011年
10期
1064-1068
,共5页
苏伟%朱贵东%刘福生%姜中利%金贵善%柴奇%曹泽%聂秀涛
囌偉%硃貴東%劉福生%薑中利%金貴善%柴奇%曹澤%聶秀濤
소위%주귀동%류복생%강중리%금귀선%시기%조택%섭수도
神经胶质瘤%Smad2%免疫组织化学%逆转录聚合酶链反应%预后
神經膠質瘤%Smad2%免疫組織化學%逆轉錄聚閤酶鏈反應%預後
신경효질류%Smad2%면역조직화학%역전록취합매련반응%예후
Glioma%Smad2%Immunohistochemistry%RT - PCR%Prognosis
目的 探讨Smad2基因在人脑胶质瘤组织中的表达情况,与细胞增殖指数Ki-67及患者生存期的关系.方法 对80例人脑胶质瘤组织标本,用免疫组化SP法检测Smad2、Ki -67的蛋白表达,逆转录聚合酶链反应法( RT - PCR)测定Smad2 mRNA的转录水平.Smad2蛋白表达情况与患者生存期的关系用Kaplan -Meier生存曲线表示,并采用log - rank方法分析.结果 (1) Smad2蛋白在高级别胶质瘤(Ⅲ级和Ⅳ级)中表达水平较低级别胶质瘤(Ⅱ级)明显增高(P <0.001).(2)Smad2 mRNA在高级别胶质瘤(Ⅲ级和Ⅳ级)中转录水平较低级别胶质瘤(Ⅱ级)增高(P<0.05).(3)Smad2蛋白阳性表达与Ki -67阳性表达呈正相关(r=0.812,P<0.001).(4)将所有患者分为Smad2高表达组和低表达组,两组间生存率差异有统计学意义(P<0.05).结论 Smad2的转录和蛋白表达水平在恶性胶质瘤中显著增高,检测Smad2表达水平有利于脑胶质瘤的恶性程度判断及对患者预后的评估.
目的 探討Smad2基因在人腦膠質瘤組織中的錶達情況,與細胞增殖指數Ki-67及患者生存期的關繫.方法 對80例人腦膠質瘤組織標本,用免疫組化SP法檢測Smad2、Ki -67的蛋白錶達,逆轉錄聚閤酶鏈反應法( RT - PCR)測定Smad2 mRNA的轉錄水平.Smad2蛋白錶達情況與患者生存期的關繫用Kaplan -Meier生存麯線錶示,併採用log - rank方法分析.結果 (1) Smad2蛋白在高級彆膠質瘤(Ⅲ級和Ⅳ級)中錶達水平較低級彆膠質瘤(Ⅱ級)明顯增高(P <0.001).(2)Smad2 mRNA在高級彆膠質瘤(Ⅲ級和Ⅳ級)中轉錄水平較低級彆膠質瘤(Ⅱ級)增高(P<0.05).(3)Smad2蛋白暘性錶達與Ki -67暘性錶達呈正相關(r=0.812,P<0.001).(4)將所有患者分為Smad2高錶達組和低錶達組,兩組間生存率差異有統計學意義(P<0.05).結論 Smad2的轉錄和蛋白錶達水平在噁性膠質瘤中顯著增高,檢測Smad2錶達水平有利于腦膠質瘤的噁性程度判斷及對患者預後的評估.
목적 탐토Smad2기인재인뇌효질류조직중적표체정황,여세포증식지수Ki-67급환자생존기적관계.방법 대80례인뇌효질류조직표본,용면역조화SP법검측Smad2、Ki -67적단백표체,역전록취합매련반응법( RT - PCR)측정Smad2 mRNA적전록수평.Smad2단백표체정황여환자생존기적관계용Kaplan -Meier생존곡선표시,병채용log - rank방법분석.결과 (1) Smad2단백재고급별효질류(Ⅲ급화Ⅳ급)중표체수평교저급별효질류(Ⅱ급)명현증고(P <0.001).(2)Smad2 mRNA재고급별효질류(Ⅲ급화Ⅳ급)중전록수평교저급별효질류(Ⅱ급)증고(P<0.05).(3)Smad2단백양성표체여Ki -67양성표체정정상관(r=0.812,P<0.001).(4)장소유환자분위Smad2고표체조화저표체조,량조간생존솔차이유통계학의의(P<0.05).결론 Smad2적전록화단백표체수평재악성효질류중현저증고,검측Smad2표체수평유리우뇌효질류적악성정도판단급대환자예후적평고.
Objective To investigate the expressions of Smad2 gene in human gliomas,and to explore whether the expression of Smad2 associate with pathologic grading and the expression of Ki - 67.Methods The expression of Smad2 mRNA was examined by reverse transcription polymerase chain reaction ( RT - PCR) and its protein was detected by SP immunohistochemistry in 80 human glioma specimens.The results were analyzed with statistic methods.The comparison of Kapan - Meier survival curves of overall survival time according to Smad2 expression was analyzed by log - rank method.Results ( 1 ) The expression of Smad2 protein increased in high grade glioma ( Ⅲ and Ⅳ ),while it decreased in low grade glioma ( Ⅱ ) significantly ( P < 0.001 ).( 2 ) The level of Smad2 mRNA transcription increased in high grade glioma,while it decreased in low grade glioma ( P < 0.05).(3) The expressions of Smad2 and Ki -67 had positive correlation ( r =0.812,P <0.001 ).(4) According to integrated optical density of Smad2,all patients were divided into two groups,Low Smad2 and High Smad2.Overall survival time was significantly different between the two groups ( P < 0.05 ).Conclusion The expression of Smad2 protein and the level of mRNA transcription increases significantly in malignant gliomas.Detecting Smad2 protein or mRNA in human glioma can be used for judging the malignancy degree and the prognosis.